title: Dietary exposure of broiler breeders to aflatoxin results in immune dysfunction in progeny chicks.
abstract: Broiler breeder hens were fed diets amended with 0 and 10 mg/kg (Trial 1) or 0, 0.2, 1, or 5 mg/kg (Trial 2) of aflatoxin (AF). Fertile eggs collected during 14 d of AF feeding were examined for AF residues. Various immunological endpoints were examined in chicks hatched from these eggs. Eggs collected at 7 d of AF feeding (Trial 1) had 0.15 to 0.48 ng/g of AFB1 and 0.22 to 0.51 ng/g of aflatoxicol, whereas eggs collected at 14 d of AF feeding had 0.05 to 0.60 ng of AFB1/g and 0.19 to 1.20 ng of aflatoxicol/g. In both trials, AF dietary exposure resulted in embryonic mortality and reduction in hatchability compared to controls. The AF progeny chicks in Trial 2 had total anti-SRBC antibodies similar to the controls during the primary antibody response. However, at 5 and 7 d after secondary SRBC injection, the antibody levels in the 1 and 5 mg/kg AF groups were lower than those of controls. Depression in anti-Brucella abortus antibodies occurred only in chicks from the 5 mg/kg AF group. Furthermore, phagocytosis of SRBC and reactive oxygen intermediate production by macrophages from AF progeny chicks were reduced as compared with the control chicks. The findings of this study imply that the progeny chicks from hens consuming a AF-amended diet may be increasingly susceptible to disease owing to suppression of humoral and cellular immunity.
authors.affiliation: Department of Poultry Science, North Carolina State University, Raleigh 27695-7608, USA. m_qureshi@ncsu.edu
authors.forename: M A
authors.initials: MA
authors.lastname: Qureshi
authors.forename: J
authors.initials: J
authors.lastname: Brake
authors.forename: P B
authors.initials: PB
authors.lastname: Hamilton
authors.forename: W M
authors.initials: WM
authors.lastname: Hagler
authors.forename: S
authors.initials: S
authors.lastname: Nesheim
mesh_terms: D016604:Aflatoxin B1 / Q000493:pharmacokinetics / Q000494:pharmacology; D000348:Aflatoxins / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D000704:Analysis of Variance; D000821:Animal Feed; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D001230:Aspergillus; D002003:Brucella abortus / Q000276:immunology; D002273:Carcinogens / Q000493:pharmacokinetics / Q000494:pharmacology; D002642:Chick Embryo; D002645:Chickens / Q000276:immunology*; D005260:Female; D005298:Fertility; D008264:Macrophages / Q000187:drug effects / Q000276:immunology; D010058:Oviposition; D010587:Phagocytosis / Q000187:drug effects; D017382:Reactive Oxygen Species / Q000378:metabolism
chemical_list: D000348:Aflatoxins; D002273:Carcinogens; D017382:Reactive Oxygen Species; C012170:aflatoxicol; D016604:Aflatoxin B1